Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
14:10
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

13th International Conference on Malignant Lymphoma

 

17-20 June 2015 Lugano
FAQs
   
Discussion forum - 13th International Conference on Malignant Lymphoma
    Topic - Aggressive B-cell lymphoma

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 213
Visits: 79
Title: Clinical and Treatment-Related Features Determining the Risk of Late Relapse in Patients with Diffuse Large B-cell Lymphoma
Authors: Lena Modvig , Maja VaseFrancesco dAmore
Centre: Aarhus University Hospital

You must be registered to reply or comment.

CLINICAL AND TREATMENT-RELATED FEATURES DETERMINING THE RISK OF LATE RELAPSE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

Lena Modvig
Thread initiator
Subspeciality
Reg: 6/4/2015 10:36:00 PM
Comment# 1
I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.

Comment added on 6/4/2015 10:36:00 PM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center

Poster most viewed in this topic
Poster: 154
Visits: 188
Title: NR4A3 suppresses lymphomagenesis by induction of apoptosis and serves as a drug target for lymphoma therapy
Authors: Alexander Deutsch ,
Centre: Clinical Devision of Hematology


 




PosterSessionOnline
Logo Draft
 
Logo Cert